0
Oxford. We characterised the relationships between gene constraint and gene function by considering Mouse 1 4 0
Phenotype ontology (MP) annotations from gene knockouts conducted by the IMPC (release 9.1). We 1 4 1 grouped 5,486 gene knockouts studied by the IMPC by their top-level MP terms. Each gene was 1 4 2 included a maximum of once for each top-level term grouping, and top-level terms with less than 50 1 4 3 associated genes were removed from the analysis. IMPC knockouts are subject to a standardised 1 4 4 phenotyping pipeline; however, there is some variation in which phenotyping tests are performed due 1 4 5
to differences in knockout lethality and funding limitations. We therefore compared funZ between all 1 4 6 knockouts annotated with a top-level MP (i.e. knockouts that passed a significance threshold of 1 4 7 0.0001 in one of the associated phenotyping tests), with all knockouts that do not have the top-level 1 4 8
MP annotation but were subject to one or more of the associated phenotyping tests. We used Mann-1 4 9
Whitney U tests with a Bonferroni correction for multiple testing to assess differences between the 1 5 0 groups (figure 4, supplementary table 6). Eleven of the 21 top-level MP terms comprised genes that 1 5 1 were significantly (p < 0.05) more constrained than genes that were tested for but did not have the 1 5 2 top-level MP annotation, with the greatest difference for mortality/aging, craniofacial, and 1 5 3 growth/size/body category phenotypes (figure 4, supplementary table 6). It is of note that the subset of 1 5 4 1,339 knockouts with no IMPC MP annotations are significantly less constrained than the average for 1 5 5 all knockouts (p = 2.4e-16).
1 5 6 1 5 7
Genes can affect multiple, often seemingly unrelated, phenotypes, and this phenomenon is known as 1 5 8
pleiotropy. We hypothesised that the more phenotypes a gene affects (the more pleiotropic a gene is), al 2014). Keyword searches included "haploinsufficiency", "dominant-negative", "de novo", and 1 9 3 "recessive", in addition to a list of all OMIM disease genes. We used logistic regression to assess the 1 9 4 difference in funZ between mouse one-to-one orthologues of human genes with no OMIM disease 1 9 5 gene association (n=9,906), and each of the OMIM gene lists, and assessed predictive power as ROC 1 9 6 (table 1). We benchmarked the predictive power of mouse funZ against funZ for the human gene, All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/657981 doi: bioRxiv preprint increase in funZ in the mouse orthologue. This suggests gene constraint can be in part explained by 2 1 5 variants in more constrained genes having an increased likelihood of being pathogenic. We quantified mouse gene constraint genome-wide, and compared intraspecific constraint between 2 2 2 human and mouse orthologues. Our research has three main findings: First, genic constraint is 2 2 3 positively correlated between human and mouse orthologues. This correlation is not, however, 2 2 4 consistent between orthology types. We show that constraint is more closely correlated between one-2 2 5
to-one orthologues than one-to-many and many-to-many orthologues. This is consistent with previous Estimates of gene constraints are dependent on methodological assumptions and the source of genetic 2 3 9
variation on which they are based (Bartha et al 2018). To calculate constraint for mouse genes we 2 4 0 used sequence variation from 36 mouse strains that have been inbred to achieve homology of genetic 2 4 1 All rights reserved. No reuse allowed without permission.
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The probability of a DNA sequence incurring a substitution mutation is in part dependent on its local reference and alternate bases is the "ancestral" and "mutant"). We inferred the ancestral and mutant 3 0 7 bases for each SNV following two assumptions: a) the ancestral base is the reference base, or the 
1 2
Trinucleotide mutation rate probabilities estimated for the human and mouse lineages are highly 3 1 3 correlated (r(190)=0.995, p=2.0e-192)(supplementary figure 1) . We used the trinucleotide mutation 3 1 4 rate probability tables to estimate the probabilities of incurring synonymous and functional mutations 3 1 5
for human and mouse genes by considering the coding consequences for each potential substitution in 3 1 6 the canonical transcript, and totalling the trinucleotide specific probabilities of mutation.
1 7
Trinucleotide mutation rate tables and gene-specific probabilities of mutation for humans and mice 3 1 8
are provided in the supplementary information.
3 1 9 3 2 0
Calculating regional and intron mutation rates 3 2 1 3 2 2
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The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/657981 doi: bioRxiv preprint Mutation rates vary throughout the genome (Hodgkinson and Eyre-Walker 2011). We therefore 3 2 3 estimated the regional mutation rate for each gene by counting the number of SNVs within the genes 3 2 4 start and end coordinates plus 1Mbp upstream and downstream, and dividing by the difference 3 2 5
between the start and end coordinates plus 2,000,000. In addition, we estimated the intron mutation 3 2 6 rate for each gene canonical transcript by dividing the number of intron SNVs (MAF > 0.001) with 3 2 7 the sum of intron lengths. Regional mutation rates for human and mouse genes are provided in the 3 2 8 supplementary information. group. We discarded top-level MP terms with less than 50 associated knockouts. We also curated a 3 6 9
list of genes that have been knocked out by the IMPC, but have no MP annotations. IMPC knockouts 3 7 0 are subject to different phenotyping pipelines due to due to differences in lethality and ethical 3 7 1 limitations. We therefore compared funZ between all knockouts annotated with a top-level MP (ie 3 7 2 knockouts that passed a significance threshold of 0.0001 in one of the associated phenotyping tests),
7 3
with all knockouts that do not have the top-level MP annotation but were subject to one or more of the 3 7 4 associated phenotyping tests. We used Mann-Whitney U tests with a Bonferroni correction for 3 7 5 multiple testing to assess differences between groups.
7 6 7 7
We investigated the relationship between gene constraint and the proportion of MP terms associated 3 7 8
with the IMPC knockout, to serve as a proxy for the pleiotropic effect of a gene. The proportion of 3 7 9
MP ontology annotations associated with each knockout was calculated by dividing the total MP 3 8 0
terms associated with each knockout by the potential number of MP terms (determined by the 3 8 1 phenotyping tests that were performed). We binned 5,486 IMPC knockouts by funZ from 1 to 100 3 8 2
with the least constrained genes in the 1 st bin and the most constrained genes in the 100 th bin. We Mendelian Inheritance in Man database. Keyword searches included "haploinsufficiency", 3 9 6
"dominant-negative", "de novo", and "recessive", in addition to a list of all OMIM disease genes. We 3 9 7
used univariate logistic regression models to assess the difference in constraint measured as funZ, selection. The plots are annotated for the two percent most constrained and least constrained genes in 5 7 8 red and blue respectively. 5 7 9 5 8 0 "de novo" (n=383), and "recessive" (n=687), in addition to a list of all OMIM disease genes 6 4 9
(n=1,917). We used logistic regression to assess the difference in constraint between genes with no 6 5 0 OMIM disease gene association (n=9,906), and each of the OMIM gene lists. 
